17 June 2015
ASLAN presents at BIO conference, Philadelphia
26 May 2015
ASLAN presents at Boston Biotech CEO conference
21 May 2015
ASLAN presents at the Medidata executive summit
in Taipei

Our Model
ASLAN inlicenses preclinical candidate drugs and takes them to proof-of-concept, leveraging high quality resources in Asia, then offers them back to the originator or other pharma companies for late phase global development.
ASLAN is currently looking to inlicense preclinical and early development compounds into our pipeline across a variety of therapeutic areas

Home | Our Model Our Team Our Board | Pipeline | Asset Partners | Latest News | Careers
    Our Advisors Our Investors         Execution Partners   Archive   Location

Copyright ©2010 ASLAN Pharmaceuticals Pte Ltd